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ABSTRACT 
As research into various aging-associated neurodegenerative disorders reveals their immense 
pathophysiological complexity, the focus is currently shifting from studying changes in an 
advanced disease state, to investigations involving pre-symptomatic periods, to possible 
aberrations in early life and even abnormalities in brain development. Recent studies on the 
etiology of schizophrenia and autism spectrum disorders revealed a profound impact of 
neurodevelopmental disturbances on disease predisposition, onset and progression. Here, we 
discuss how a prenatal immune challenge can affect the developing brain – with a selective 
focus on the impact on microglia, the brain’s immune cells – and the implications for brain 
aging and its associated risk of developing Alzheimer’s disease. 
 
Microglia in development 
The immune system has developed to ensure cells of the innate immune system reside in all 
organs of the body. The brain, far from being a completely immune-privileged site, as thought 
earlier, possesses its own immune cells (Ransohoff and Perry, 2009). These are the microglia, 
and are the only cells in the central nervous system (CNS) that do not originate from the 
neuroectoderm (Allen and Barres, 2009), but belong to the myeloid lineage. After some 
debate how these cells populate the CNS– either via entering the developing brain from 
peripheral circulation as monocytes followed by differentiation (Perry et al., 1985), or 
multiplying from intraparenchymal precursors that existed before the development of the 
vasculature (Alliot et al., 1999), recent studies provided supporting evidence that microglia 
derive from macrophages that originate from the yolk-sac and then colonize the brain 
(Herbomel et al., 2001; Ginhoux et al., 2010). Still, what percentage of microglia in the adult 
pool are remnants from these developmental precursors is unknown. While the predominant 
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view is that microglia are long-lived cells that are not often replenished from the periphery, 
different studies have shown that, under certain conditions, peripheral bone-marrow derived 
mononuclear phagocytes (BMDPs) can integrate into the CNS (Priller et al., 2001; 
Massengale et al., 2005; Prinz and Mildner, 2011). Moreover, differential expression of 
certain markers, for instance, Hoxb8, seem to indicate that at least two different microglial 
populations exist in the adult mouse brain (Chen et al., 2011), which may have different 
implications for their function.  
Once the microglia colonize the brain, several studies (Pont-Lezica et al., 2011) have shown 
that contrary to being randomly and evenly distributed throughout the brain, these cells appear 
to concentrate specifically at certain locations, either being associated with apoptotic neurons 
and radial glial cells, for example, or being excluded from others, like the lens and 
photoreceptor layer of the retina. The distribution of microglial cells in the brain show region-
specific differences with highest density in the hippocampus, basal ganglia, olfactory 
telencephelon and substantia nigra, followed by cerebral cortex, thalamus and hypothalamus, 
and lowest density in cerebellum brain stem areas, and myelinated fibre tracts (Lawson et al., 
1990; Lawson et al., 1993). Moreover, there even seems to be a variation in where the 
majority of the morphologically distinct microglia generally reside. Those with the shortest 
processes are found in the circumventricular regions, while the most ramified microglia are 
found in the grey matter (Lawson et al., 1990). This region-specific density, which varies 
around five-fold, as well as the differences in morphology, appears to be closely linked to the 
vast number of functions performed by microglia. 
During development, they play significant roles in the formation of a healthy working 
environment in the CNS, and accomplish this in various ways. First, microglia are found in 
close association with cells undergoing developmental cell death, and have been shown to be 
capable of phagocytosing apoptotic neurons (Peri and Nusslein-Volhard, 2008). They have 
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also been shown to control which cells undergo apoptosis, via NGF signaling or triggering 
oxidative stress (Frade and Barde, 1998; Wakselman et al., 2008). Large microglial 
populations have also been discovered free of apoptotic cells, and these are thought to have 
other functions. Those in close association with the developing vasculature have been 
suggested to play a key role in angiogenesis, as evidenced by the underdeveloped vascular 
system in mice lacking microglia (Rymo et al., 2011). Others are associated with developing 
axon tracts throughout the brain (Herbomel et al., 2001), at the right time to influence neurite 
development and axon remodeling, as well as synaptic pruning in development (Paolicelli et 
al., 2011). Microglia have been shown to contain large inclusions that often resemble axon 
terminals and even spines (Tremblay, 2012), and could contribute to experience-dependent 
remodeling of synapses and developing circuits. In line, members of the complement system, 
often derived from microglia, have also been shown to be involved in synapse elimination 
(Stevens et al., 2007). Recent research also showed that mice lacking CX3CR1 (a microglia-
specific chemokine receptor) show significant impairments in synaptic development as 
compared to wild-type littermates (for recent review, Ransohoff and Perry, 2009).  
 
Microglia functions in the adult brain 
The close and tightly regulated interaction between microglia and neurons during brain 
development is maintained in the adult brain. This has been highlighted by several studies 
recently summarized by Trembay and colleagues (2011), indicating that microglia are actively 
involved in the remodeling of the perisynaptic environment and fine-tuning of neuronal 
activity, likely also involving feedback signals provided by the neurons to modulate the state 
of activity in microglia (Tremblay et al., 2011). This bidirectional communication is achieved 
through interactions between cell-surface receptors and cell-surface-bound ligands (i.e. 
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CD200-CD200 receptors), or at a distance after the generation of diffusible ligands, as well as 
via neurotransmission-associated inhibition involving dopamine and noradrenaline and their 
respective receptors (for recent review, Ransohoff and Cardona, 2010). In turn, through the 
release of a multitude of soluble factors including neurotrophic factors chemokines, 
cytokines, microglia not only perform classical glia functions, but also accomplish a crucial 
immune function by surveillance of the brain for damage infection, and engulfing infectious 
agents, dead cells and debris (Streit, 2006, 2009).  
Interestingly, the morphology of the cells seems closely related to function. At least two 
distinct configurations have been observed – highly branched with long, fine processes, or 
rounded and amoeboid. The former were considered to be “resting microglia” that occur in a 
healthy, undisturbed CNS. This term later proved to be a misnomer, since these cells were 
shown to be highly dynamic, forming networks with their processes, while their soma remain 
more or less stationary, that probe and test the entire brain in a matter of a few hours 
(Nimmerjahn et al., 2005; Schlegelmilch et al., 2011; Wirenfeldt et al., 2011). The onus is to 
designate these microglia more appropriately as “surveying microglia” (Hanisch and 
Kettenmann, 2007). The amoeboid cells are indeed more active in the immune sense, with the 
surveying glia transforming to this phenotype, possessing upregulated antigen presenting 
molecules, when phagocytosis is required. This rapid conversion to the amoeboid form is 
termed “activation of microglia” and can be triggered by a variety of stimuli, ranging from 
infection and trauma to ischemia or any disturbance in the normal functioning of the brain 
(Kettenmann et al., 2011).  The abrupt response to neuronal injury could also be related to a 
disrupted cell-cell contact and the concomitant loss of neuron-mediated inhibition of 
microglia (for recent review, Ransohoff and Cardona, 2010). Whether these properties also 
relate to the observed differences in the basal activation state of microglia in white versus 
grey matter (Carson et al., 2007), remains to be determined. However, it is conceivable that 
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these functional differences are linked to the expression profile of cell surface markers, 
through which microglia are not only able to control distinct population of neurons but also 
modulate a variety of cellular and immune functions (for recent review, Lynch, 2009). For 
instance, microglia can promote the infiltration of circulating cells into the CNS (upregulation 
of CD11b), can be non-phagocytic and produce proinflammatory molecules (CD40), or be 
phagocytic and motile (MHCII), as shown for the highly effective clearance of   In the adult 
brain, microglia are responsible for all apoptotic debris, including the majority of new born 
neurons (Sierra et al., 2010). 
Based on morphology, it is thus possible to differentiate microglia into functionally different 
states including amoeboid (surveilling) and ramified (activated) forms. A third potential state 
has recently been hypothesized, by postulating that microglia can devolve from their 
“surveying” state into an “alerted” one, before becoming fully activated. This resembles the 
process of priming of macrophages in the periphery, where activation occurs in two steps – 
priming, followed by triggering (Dilger and Johnson, 2008). A “primed” microglial cell 
would thus react to a greater degree than a non-primed one. In line with these hypothesis, 
once activated, microglia tend not to return all the way to their “surveying” state, thereby 
eliciting elevated responses to the next stimulus (Schwartz et al., 2006). Microglia differ, 
however, from peripheral immune cells in their preference for humoral responses rather than 
eliciting the classical cytotoxic responses, which involves the ingestion of antigens, exiting 
the tissue and entering the draining lymph nodes, where stimulation of naive T cells occurs. 
This happens perforce due to the nature of the CNS environment – where the neurons cannot 
regenerate as easily as cells in the periphery, and collateral damage cannot be repaired.  
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Microglia in Disease and Aging  
Several diseases, not only those of the CNS, appear to impact on microglial activity and 
function. Infectious diseases of the CNS (Mariani and Kielian, 2009), conditions of 
neuropathic pain (Ji and Suter, 2007), even air pollution (Block and Calderon-Garciduenas, 
2009) can create environments where microglia become highly activated, and after a point, 
cannot protect the CNS any more. Looking at two neurodegenerative diseases – MS and 
traumatic spinal cord injury (SCI) – the role of microglia in repairing the damage is 
highlighted. In cases of MS or other demyelinating conditions, it has been shown that there 
exists a subset of microglia at the site of demyelination that can recruit oligodendrocyte 
precursor cells and phagocytose damaged neurons (Olah et al., 2011). In SCI, cells of the 
myeloid origin have been shown to play a role in intraspinal trafficking past the injury 
(Hawthorne and Popovich, 2011).  
Beyond diseases, aging also represents a critical “primer” of microglia activity, and is also 
accompanied by microglial dystrophy and degeneration, a feature that appears to be 
accompanied by diminution of microglial neuroprotective functions and hypothesized to 
significantly contribute to neurodegenerative changes characteristic of AD (Streit, 2004). A 
combination of microglia senescence on one side and priming-related hyperactivity on the 
other side is therefore expected to have a detrimental influence on neuronal health. This 
represents a highly relevant theory regarding AD pathogenesis because it integrates aging as 
the most important risk factor of this progressive neurodegenerative disease. However, the 
molecular mechanisms underlying aging-associated microglia dysfunction are largely 
unknown. Besides a decline in proteasome activity and other aging-associated impairments in 
protein homeostasis (Stolzing and Grune, 2003), limited information is available regarding 
the lifespan of microglia (Streit, 2006).  It has been shown that nerve injury induces – beside 
recruitment of bone marrow-derived precursors that can infiltrate the brain - a burst in mitotic 
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activity and a wave of proliferation that is followed by apoptotic cell death of microglia 
(Graeber et al., 1988; Gehrmann and Banati, 1995; Lassmann et al., 1995). This represents an 
essential defense and wound healing mechanism shown to be maintained in aged rodents 
(Conde and Streit, 2006) and suggested to be required to keep the number of these 
endogenous immune defenders of the CNS constant. It is conceivable, therefore, that 
repetitive exposures to brain injury and inflammation induces replicative senescence, eventual 
loss of mitotic activity and degeneration of microglia during aging. Evidence for this 
hypothesis has been provided by in vitro findings showing that microglia stimulation by 
mitogens induces telomere shortening (Flanary and Streit, 2004). Recent data also showed 
that interferon-γ exposure is sufficient to trigger activation-induced microglia cell death (Yun 
et al., 2011), in line with postmortem investigations of AD patients showing caspase activity 
in plaque-associated microglia in AD (Yang et al., 1998). 
Specifically with respect to AD, the significance between the association of microglia with 
amyloid plaques has long been debated. Several studies have looked at the possibility of using 
the phagocytic ability of microglia therapeutically to clear the plaques, but largely, this 
doesn’t seem to have the desired results on cognition. It has further been observed that 
plaque-associated microglia still possess their processes at the interface, and are capable of 
phagocytosing Aβ peptides (Bolmont et al., 2008). However, it has also been demonstrated a 
that microglia show an age-dependent reduction in their ability to clear Aβ peptides, despite 
preservation of functional phagocytic activity and even adherence to Aβ plaques (Floden and 
Combs, 2011), underscoring the importance of aging for microglial health and activity. 
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Prenatal PolyI:C model of accelerated aging 
Interestingly, degeneration of microglia has also been reported in neurological disorders 
without major neurodegenerative changes, such as schizophrenia, (Wierzba-Bobrowicz et al., 
2004), or associations with aging. Besides genetic risk factors, maternal infection during 
pregnancy represents one of the currently most extensively studied risk factor in experimental 
schizophrenia research. This is based on a large body of epidemiological data that has 
provided compelling evidence for enhanced risk of schizophrenia following prenatal exposure 
to infection with various viral or bacterial pathogens, or genital and/or reproductive infections 
(Brown et al., 2006; Patterson, 2007; Boksa, 2008). This data indicates that the early 
inflammatory insult not only strongly affects the developing nervous system and predisposes 
the offspring to psychosis-related behavioural abnormalities in adulthood, but likely also 
critically influences the proliferation, maturation and function of the developing immune 
system. The findings of significantly elevated levels of degenerating microglia seen in frontal 
and temporal cortices of schizophrenia patients compared to healthy subjects (Wierzba-
Bobrowicz et al., 2004) indeed supports the hypothesis that early prenatal infection-induced 
expression of pro-inflammatory cytokines and other mediators of the innate immunity might 
reduce the proliferative capacity of microglia and hence reduce their lifespan.  
To investigate the impact of a prenatal infection on brain and immune system development, 
we established a mouse model that is based on the critical contribution of the gestational stage 
during which the maternal immune challenge occurs. It builds on findings reported by other 
groups that demonstrated a wide spectrum of behavioural, neuroanatomical, and 
neurochemical changes following exposure to viral or bacterial pathogens in rats and mice 
that mimicked critical phenotypic symptoms of schizophrenia (for recent review, (Meyer et 
al., 2009). Based on the highly comparable phenotype induced by the various types of 
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pathogens we reasoned that the downstream effects, i.e the production of pro-inflammatory 
cytokines might be the critical common denominator of the behavioural and neurochemical 
changes described. To test this, we employed a viral mimic, Polyriboinosinic-
polyribocytidilic acid (PolyI:C), a double-stranded RNA shown to bind to Toll-like receptor 3 
(TLR3), leading to activation of nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) and production of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-12 
(Alexopoulou et al., 2001; Okun et al., 2011). Given the critical processes during the 
development of the brain and its resident immune cells, we decided to contrast early, mid- and 
late-gestational stages. We hypothesize that the developmental stage critically determines the 
phenotype of the adult offspring, allowing us to test whether prenatal infections may – in 
addition to the widely accepted role in the etiology of neuropsychiatric diseases – also 
contribute to brain aging and neurodegenerative diseases.  
Our first findings indeed confirmed that the time of maternal immune challenge critically 
determines the patterns of fetal immunological, juvenile neurochemical, as well as adult 
behavioural abnormalities displayed by the offspring (Meyer et al., 2006). While the PolyI:C 
challenge during early-gestation (gestational day 6, GD6) resulted in a high incidence of 
abortion, a viral-like infection during mid-gestation (GD9) confirmed the precipitation of 
psychosis-related symptoms in the adult offspring, in line with previous findings by other 
groups (Borrell et al., 2002; Shi et al., 2003; Zuckerman et al., 2003; Zuckerman and Weiner, 
2005; Ozawa et al., 2006; Romero et al., 2007). A late-gestational (GD17) immune challenge 
resulted in a behavioural phenotype characterized by cognitive impairments, elevation of fetal 
IL6, IL10, and TNFα, enhanced apoptosis in the dentate gyrus, as well as a decline in Reelin-
positive cells in juvenile brains (Fig. 1). We showed for the first time that the fetal brain can 
directly contribute to the specific changes in inflammatory cytokine protein levels after late-
gestational but not mid-gestational immune challenge, suggesting a close correlation between 
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acute immunological modulators and histopathological changes in the juvenile offspring. We 
also reported that the mid- and late-gestational infections had a differential impact on the 
developing neurotransmitter systems (Meyer et al., 2008). Using immunohistochemical 
approaches and unbiased stereological evaluations, we provided first evidence that a prenatal 
immune challenge around mid-gestation has a stronger impact on the prefrontal dopamine 
receptor D1 expression as compared to the treatment effect at GD17. These neurochemical 
alterations were accompanied with behavioural abnormalities with relevance to positive 
symptom clusters characteristic of schizophrenia. On the other hand, an in utero immune 
challenge at GD17 preferentially affected the expression levels of the hippocampal NR1 
subunit of the NMDA receptor as compared to GD9 and control treatments, which were 
paralleled by impairments in working memory performance. These studies revealed also that 
a prenatal immune challenge during late gestation resulted in acceleration of aging, as 
indicated by the earlier formation of Reelin-positive extracellular amyloid-like deposits, a 
neuropathological feature detected in the hippocampal formation in several species that is 
accompanied by a reduction in Reelin-expressing neurons (Knuesel et al., 2009; Knuesel, 
2010). Both neuropathological alterations significantly correlated with hippocampus-
dependent episodic-like memory deficits (Knuesel et al., 2009). We found that healthy and 
cognitively normal subjects were able to sufficiently clear and degrade these deposits, 
whereas cognitively impaired aged mice failed to do so. Our results showed for the first time 
that prenatal exposure to infection during late embryonic developmental stages is not only an 
important factor in the segregation of certain behavioural symptom clusters with relevance for 
neuropsychiatric disorders but does also represent a critical driving force of aging-related 
neuropathological processes.  
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Effects of PolyI:C in vitro and in vivo on Microglia 
These observations indicated that the effect of PolyI:C on microglia and astrocytes could be 
highly relevant for such neuropathology. Supporting this view, our studies with primary 
cultures of these cells revealed that PolyI:C could trigger the morphological changes 
underlying the transformation of microglia into their activated state, as compared to the 
ramified morphology of the untreated, or saline treated, surveying microglia, but not changes 
in astrocyte morphology (Fig. 2; Vogel et al., unpublished data). The implication here is that 
PolyI:C induces a strong and distinct immune response through the TLR3 found on microglia, 
but saline, a likely stressor, activates different cellular pathways, leading only to a mild or 
non-selective immune response. 
The mRNA of different TLRs has previously been shown to be enriched in the vicinity of 
amyloid plaques (Frank et al., 2009), likely reflecting their localization on microglia. Our own 
observations in aged prenatally immune-challenged mice reveal a striking overlap between 
microglial and TLR3 immunoreactivity (Vogel et al., unpublished data). Besides establishing 
a chronic adverse neuronal environment, the prenatal immune challenge might prime 
microglia and thereby alter their ability to react to different stimuli and create an innate 
memory allowing a faster and exaggerated response upon a second challenge; changes highly 
comparable to mechanisms in the adaptive immune system. The strong glial response may 
then have devastating effects on surrounding neurons resulting in demyelination and 
apoptosis due to release of ROS.  
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New Perspectives and Future Outlooks 
Having seen how delicately balanced the immune system is in the CNS, it becomes more 
evident that inflammation at critical points during development can have a serious and long-
lasting impact on microglial function, and thus, on how the brain ages. Studying microglia 
during development and understanding the different aspects of their priming and activation 
could provide insights to disorders that set in much later in life, like AD. Everyone’s goal of 
healthy aging seems thus to depend more on proper developmental processes than so far 
anticipated. 
 
METHODS 
Animals All experimental procedures were approved by the local authorities of the Cantonal 
Veterinary Office in Zurich and are in agreement with the Principles of Laboratory Animal 
Care (NIH publication No. 86-23, revised 1985). 
Preparation of primary neuronal cultures Pregnant rat dams were sacrificed at gestation 
GD18. Rat embryos were decapitated, the brain removed and immediately put in ice-cold 
PBS/glucose. The dissected cortices of 2 to 4 animals were transferred into a tube containing 
ice-cold PBS/glucose. The PBS/glucose was aspirated and the cortices were passed through a 
100 µm and a 70 µm cell strainer in 50 ml DMEM supplemented with 20% FCS, L-Glut and 
gentamicin (all from Gibco Life technologies, Invitrogen Inc.). The cell suspension was 
seeded in a 170 cm2 cell culture flask. After 7 days in culture, the medium was changed to 50 
ml astrocyte culture medium. The astrocytes were grown for another 5 to 7 days in vitro 
before the microglia were mechanically detached using a plate shaker running at 2000 
rotations per minute (rpm) for 30 minutes. The medium was aspirated, the attached astrocytes 
were once washed with pre-warmed PBS and 9 ml trypsin (Sigma-Aldrich) diluted in PBS 
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added for 5 minutes at 37°C. In order to inactivate the trypsin, 1 ml FCS was added. The 
astrocytes were collected and spun down for 5 minutes at 1100 rpm. The supernatant was 
removed and the astrocytes were gently dissociated in astrocyte culture medium with a fire-
polished Pasteur pipette. 10 µl of the single cell suspension was mixed with 10 µl Trypan 
Blue dye exclusion medium and the live cells were counted using a Neubauer chamber. The 
suspension was diluted to 50’000 cells per coverslip and 200 µl was plated on Poly-L-Lysine 
(Sigma-Aldrich) coated glass coverslips. After 2 hours in vitro, the coverslips were 
transferred in astrocyte culture medium in a 12-well plate. The culture plates were maintained 
at 37°C in an atmosphere of 5% CO2. After 3 to 7 days, the astrocytes were fixed and stained 
to assess the purity of the culture. 
Cell stimulation PolyI:C (200 μg/ml, P9582, Sigma) was solved in 0.9 % pyrogen-free NaCl 
(B. Braun, 534534) and directly added to the medium of primary astrocyte cultures after 3 
days in vitro.  
Immunocytochemistry At 7 days in vitro, the cells were fixed for 15 minutes with 4% PFA at 
RT and rinsed 3 times with PBS. Subsequently, the cells were permeabilized 4 to 5 minutes 
with 0.2% Triton X-100 solution (Fluka) in PBS supplemented with 10% Normal Goat Serum 
(NGS; Serotec) at RT. The cells were then incubated with the primary antibody (rabbit anti-
Iba1, 1:4000, Wako Nr. 019-19741; mouse anti-GFAP, 1:5000, Dako, Z334) diluted in PBS 
containing 10% NGS for 90 minutes at RT. In the following, the cells were washed 3 times 10 
minutes with PBS and then incubated with the secondary goat-anti-rabbit-Cy3 (Jackson 
ImmunoResearch Inc, 1:500) and goat-anti-mouse-Alexa488 (Invitrogen Inc, 1:1000) 
antibodies diluted in PBS containing 10% NGS for 30 minutes at RT. The cells were dried 
and covered upside-down with fluorescent mounting medium containing DAPI (Thermo 
Scientific Pierce Inc.) on glass slides. 
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Microscopy and ditital imaging Triple-immunofluorescence labelings were visualized by 
confocal microscopy (LSM-710, Zeiss, Jena, Germany) using a 40x (NA 1.3) and 63x (NA 
1.4) and sequential acquisition of separate channels. Z-stacks of consecutive optical sections 
were summed and projected in the z dimension (maximal intensity) and merged using the 
image analysis software Imaris (Bitplane, Zurich, Switzerland) for visual display. Cropping of 
images, adjustments of brightness and contrast were identical for each labeling and done 
using Adobe Photoshop.  
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FIGURE LEGENDS 
 
Figure 1: Schematic representation of the critical differences resulting from a prenatal 
immune challenge at different time periods in gestation. 
 
Figure 2: Glial cells in prenatal astrocyte cultures undergo morphological change upon 
immune stimulation. A - B, Immunofluorescence staining of astrocytes using anti-GFAP 
antibody (green) and microglia labeled with anti-Iba1 antibody (red) in astrocyte cultures 
prepared from E18 rats. The nuclei were counterstained with DAPI (blue). Immune challenge 
with PolyI:C altered the ramified phenotype found in untreated and NaCl-treated cultures into 
an amoeboid-like appearance indicative of activated microglia. Note, that also GFAP-positive 
astrocytes change their morphology following PolyI:C exposure. Scale bar: A: 50 µm, B: high 
magnification image: 15 µm. 
 


